Silvercrest Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $445K | Sell |
5,360
-225
| -4% | -$18.7K | ﹤0.01% | 724 |
|
|
2025
Q1 | $453K | Sell |
5,585
-350
| -6% | -$28.4K | ﹤0.01% | 717 |
|
|
2024
Q4 | $535K | Buy |
5,935
+100
| +2% | +$9.01K | ﹤0.01% | 681 |
|
|
2024
Q3 | $576K | Hold |
5,835
| – | – | ﹤0.01% | 635 |
|
|
2024
Q2 | $541K | Hold |
5,835
| – | – | ﹤0.01% | 705 |
|
|
2024
Q1 | $554K | Buy |
5,835
+10
| +0.2% | +$949 | ﹤0.01% | 691 |
|
|
2023
Q4 | $520K | Hold |
5,825
| – | – | ﹤0.01% | 658 |
|
|
2023
Q3 | $425K | Hold |
5,825
| – | – | ﹤0.01% | 700 |
|
|
2023
Q2 | $485K | Hold |
5,825
| – | – | ﹤0.01% | 680 |
|
|
2023
Q1 | $444K | Buy |
+5,825
| New | +$444K | ﹤0.01% | 667 |
|